What's up with GILD Stock?

Never thought I'd see the stock under 60$ again. What's up?

 

Well, what is NOT up is the stock price. As you are keenly aware.

 

On a positive note we are now almost exclusively focused on diversity and inclusion which is reflected in our share price

 

KARMA

 

Being facetious and sarcastic I see! However, I do agree that it is a LONG OVERDUE “positive note.”

 

Nothing better than hearing a “qualified” diversity hire not able to figure out mute and talk jive for 5 minutes over the speaker

 

Nothing better than continually watching “qualified” non-diversity, privileged “leadership” hires struggle to get the stock price above $60 while two supposed blockbuster pipeline products flame out (NASH & filgo). Not to mention the heavy oncology investments that clearly investors aren’t impressed and have delivered no ROI. Gotta love privileged “leadership!”

 

The stock plunge is real, and happened when Gilead began focusing on promoting and hiring the unqualified - we all now pay the price (And yes I did hear that diversified guy today on a National call not able to figure out mute, embarrassing)

 

The “unqualified” you referenced certainly aren’t persons of color. It’s the usual cast of privileged and unqualified persons that tanked the stock price. The privileged and unqualified are the ones making ALL of the decisions and they’ve done nothing for investors to be excited. They have, however, figured out how to squander the pile of cash they had with no ROI. Thus, we have the privileged and unqualified to thank for the stock price.

 

Can GILD at least HOLD $60? WTF is wrong with this co.? Dead money.

RSUs, ESPP are nice but what if the SP actually went up? I want to live in that world...

 

Another example of "unqualified" is hiring back a bunch of laid off Gilead reps to the new IS Veklury team even if they don't have hospital experience. They're launching their first hospital team and yet they hire people who aren't well versed in hospital?? I'd call that unqualified. Winning awards in an office based territory is very different than doing it in the hospital. Relationships don't rule and managed care plans don't either. It's all about strategy and understanding the business, I don't care what your color or how privileged you may or may not be.

 

Stock is done. HIV missing revenues. Onc is a disaster. Can’t get out of their own way. HCV is over. DOD should spend less time on ERGs and more time on M&A’s.

 

Gilead axed 179 in FC. Field next?

 

65-75 range until Oncology products launches then 2023 stock goes over 100

 

Need some billion a yr products and not little penny products like Kite or CF has.
Blockbusters if want stock to get to 200.
Or have big pharma like AZ Merck overpay 200 for us

 

Going up now

 

Need to buy a good co with good products not swamp land with sink holes in the middle!

 

Keep drinking the kool- aid

 

Yeah, inferior oncology products that is. Transformative products is a big fricking joke. AZ is going to kick ass with Enhertu.